Neosporosis: An Overview of Its Molecular Epidemiology and Pathogenesis

  • Asis Khan a ,
  • Jahangheer S. Shaik a ,
  • Patricia Sikorski a ,
  • Jitender P. Dubey b ,
  • Michael E. Grigg a
Expand
  • a Molecular Parasitology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National
  • Institutes of Health, Bethesda, MD 20892, USA
  • b Animal Parasitic Disease Laboratory, Beltsville Agricultural Research Center, Agricultural Research Service, US Department of
  • Agriculture, Beltsville, MD 20705, USA

Received date: 16 Sep 2018

Published date: 24 Jan 2020

Abstract

Neospora caninum (N. caninum), a cyst-forming protozoan parasite, is a major cause of bovine abortions and neonatal mortality worldwide. N. caninum has a broad intermediate host range, and its sexual cycle occurs exclusively in canids. Another species of Neospora, N. hughesi, has been identified and causes myeloencephalitis in horses. Although molecular epidemiology studies are in their infancy, the 18S rRNA and ITS1 regions within the ssuRNA and an N. caninum species-specific DNA probe (pNc5) have been used extensively to differentiate Neospora from other closely related apicomplexan parasites. While these repetitive regions have higher sensitivity and specificity than housekeeping or antigen genes, they suffer from low discriminatory power and fail to capture intra-species diversity. Similarly, although multiple minisatellite or microsatellite marker studies have shown clear geographic substructures within Neospora, strains are often misclassified due to a convergence in the size of different alleles at microsatellite loci, known as homoplasy. Only one strain, N. caninum Liverpool (Nc-Liv), has been genome sequenced and compared with its closest relative, Toxoplasma gondii (T. gondii). Hence, detailed population genomics studies based on wholegenome sequences from multiple strains worldwide are needed in order to better understand the current population genetic structure of Neospora, and ultimately to determine more effective vaccine candidates against bovine neosporosis. The aim of this review is to outline our current understanding of the molecular epidemiology and genomics of Neospora in juxtaposition with the closely related apicomplexan parasites Hammondia hammondi and T. gondii.

Cite this article

Asis Khan , Jahangheer S. Shaik , Patricia Sikorski , Jitender P. Dubey , Michael E. Grigg . Neosporosis: An Overview of Its Molecular Epidemiology and Pathogenesis[J]. Engineering, 2020 , 6(1) : 10 -19 . DOI: 10.1016/j.eng.2019.02.010

1. Historical perspective

Neospora caninum (N. caninum ) is a coccidian protozoan parasite belonging to the apicomplexan phylum [1], and was often confused with the closely related apicomplexan parasite Toxoplasma gondii (T. gondii ) until 1988[23]. In 1984, Bjerkås et al. [4] first described cases of encephalomyelitis (brain and spinal disease) and myositis (muscular disease) in a litter of six congenitally infected Boxer pups in Norway, caused by an unidentified parasite. This parasite was formally recognized as N. caninum in 1988, based on a retrospective analysis of thousands of tissue sections from dead dogs and cats that succumbed to a Toxoplasma-like illness from 1952 to 1987 at Angell Memorial Animal Hospital in Boston, USA, which were negative for immunohistochemical reactivity with anti-T. gondii antibodies[23].

2. Life-cycle

N. caninum has a wide host range and a heteroxenous life-cycle consisting of two distinct modes of reproduction: ① asexual reproduction, which occurs in intermediate hosts; and ② sexual reproduction, which occurs exclusively in definitive canid hosts including dogs [5], coyotes [6], gray wolves [7], and dingoes [8] (Fig. 1). Although the sexual developmental stages of T. gondii are well defined, the developmental stages of N. caninum, such as schizogony and gametogony, are unknown. The only known sexual stage of N. caninum is the unsporulated diploid oocyst, which is environmentally resistant to freezing and drying. Unsporulated oocysts are shed in the feces of infected canids and undergo meiosis in the environment to form haploid sporozoites (Fig. 1) [3]. After ingestion of sporulated oocysts by the intermediate hosts, sporozoites are released from oocysts and convert into a rapidly growing stage known as tachyzoites, which disseminate the infection (Fig. 1). Tachyzoites invade host cells and replicate asexually by repeated endodyogeny within a parasitophorous vacuole (PV). After several rounds of endodyogeny, parasites egress from the host cell [9] to re-infect new host cells, subsequently generating host-specific innate and adaptive immune responses. Due to host immune responses and other environmental factors, tachyzoites convert into a slowly growing, semi-dormant stage known as bradyzoites, which are found in tissue cysts (Fig. 1). Tissue cysts can persist in a host cell for a long time and can convert into tachyzoites to generate latent infection, particularly in immunocompromised hosts [10].
Fig. 1. Heteroxenous life-cycle of N. caninum. Reproduced from Ref. [3] with permission of CRC Press, © 2017.

3. Transmission

Despite having a wide host range and a heteroxenous life-cycle, Neospora infects cattle and dogs as its primary intermediate and definitive hosts, respectively [11]. Cattle can become infected either horizontally, through the ingestion of infectious oocysts that have been shed by the definitive hosts, or vertically, through transplacental or congenital transmission from an infected pregnant mother to her fetus (Fig. 1). Vertical transmission is considered the predominant and most efficient (80%) route of transmission of Neospora in cattle herds. Vertical transmission can occur either as exogenous transmission through oocystderived infection of a pregnant heifer, or through endogenous transplacental transmission as a result of reactivated latent infection during pregnancy [3]. Fetuses infected with Neospora can abort in any gestational age, be resorbed, mummified, autolyzed, or born with persistent infection. Transplacental transmission has also been documented in other intermediate hosts, including sheep, goats, deer, and dogs. Venereal transmission though semen and transmission through milk is considered unlikely [3]. Dogs are generally infected orally via ingestion of infected intermediate host tissue. In contrast to cats, which are the definitive host of T. gondii and Hammondia hammondi (H. hammondi ) [12], dogs generally produce fewer oocysts of Neospora during sexual transmission. Given the close association of dogs and cattle in herds[15] and the likelihood of vertical transmission through generations of cattle[13,14], the probability of transmission is significantly higher because parasites can be maintained and propagated between the definitive and intermediate hosts for a long time within the same herd. This localized transmission cycle between cattle and dogs through asexual and sexual reproduction is probably shaping the population structure of Neospora.

4. Neospora hughesi

The identification of a new Neospora species, Neospora hughesi (N. hughesi ), was first reported in 1998 in a horse with equine protozoal myeloencephalitis in California, USA [15]. N. hughesi is considered to be a separate species because it is seemingly restricted to horses [15] and shows significant antigenic and sequence divergence when compared with N. caninum[1618]. For example, the surface antigen SAG1 exhibits a 6% difference in amino acid identity between NcSAG1 and NhSAG1 [16]. Thus, the NcSAG1- derived mAb 6C11 does not hybridize with N. hughesi SAG1 [16]. Similarly, another surface antigen SRS2 (NcSRS2 and NhSRS2) shows a 9% amino acid difference. The antigenic specificity demonstrated between these two abundantly expressed surface antigens has therefore been utilized to generate efficient molecular markers that differentiate between N. caninum and N. hughesi[16]. Comparative analysis of the dense granule (GRA) proteins GRA6 and GRA7 between N. hughesi and N. caninum has also revealed significant differences in both amino acid sequence and structural organization [18]. In addition to these antigenic markers, sensitive molecular-detection methods have been used, based on nucleotide sequence differences within the repetitive ITS1 region that discriminate N. hughesi from N. caninum (7–9 bp) [19].
Interestingly, these genetic differences between N. caninum and N. hughesi also confer phenotypic differences during experimental rodent infection. N. hughesi causes predominant necrosis in myocardial tissue, whereas N. caninum lesions are found predominately in the liver, lungs, and brain. Furthermore, there is a striking difference in virulence between N. caninum and N. hughesi in the gerbil (Meriones unguiculatus ) model. Gerbils are highly susceptible to oral infection with N. caninum, resulting in the death of most gerbils within 6–13 d post-infection [20]. Conversely, N. hughesi infection does not produce significant clinical signs in gerbils, with the exception of a few microscopic lesions. However, it needs to be elucidated whether the reported genetic and biological differences between these two species are due to species-specific differences or strain-specific differences, as seen for T. gondii. Experimental genetic crosses between N. caninum and N. hughesi may shed light on whether these two parasites should be considered to be separate species, as inter-specific crosses have been recently demonstrated to occur within the Leishmania field [21]. Taken together, the current consensus is that the Neospora population structure is composed of at least two separate Neospora species: N. caninum and N. hughesi, that evolved from a common ancestor and have expanded independently to adapt to their various vertebrate hosts.

5. Detection

5.1. Morphological detection
Several morphological detection methods have been developed to identify neosporosis in infected samples. Cytology by microscopic examination of cytospin smear or impression smears, followed by Diff-Quick rapid staining, Giemsa staining, and/or hematoxylin or eosin (HE) staining of lesions, is the most conventional method for the rapid detection of neosporosis in the field. However, due to morphological similarities with closely related parasites, it is difficult to differentiate Neospora from Toxoplasma and Hammondia, apart from the presence of thick-wall (up to 4 μm) tissue cysts, which is one of the hallmarks of Neospora. Transmission electron microscopy has also been used to distinguish Neospora from Toxoplasma and Sarcocystis based on the presence of electron-dense rhoptries (ROPs) in Neospora. Conversely, Toxoplasma ROPs are electron lucent, whereas ROPs are absent in Sarcocystis merozoites. Immunohistochemical staining (IHC) is another very sensitive and widely used methodology to detect neosporosis in fixed tissues[2224]. The avidin–biotin complex indirect immunoperoxidase and peroxidase–antiperoxi dase techniques are equally sensitive methods. Both monoclonal and polyclonal antibodies specific to Neospora have been utilized for IHC, with rabbit polyclonal antibodies exhibiting more sensitivity than monoclonal antibodies. Recently, however, a combination of NcSRS2 and NcGRA7 monoclonal antibodies [24] were shown to be more specific and as sensitive as polyclonal antibodies, obviating the potential for polyclonal antibody cross reactivity with T. gondii or related coccidian parasites.
5.2. Serological detection
Since the discovery of neosporosis, several serological methods have been developed for its detection. After infection, Neospora specific Immunoglobulin M (IgM) antibodies can be detected within a couple of weeks, whereas IgG antibodies take several weeks to reach detection levels, with titers peaking six months after primary infection. Several antigens have been used extensively for detection, including the surface antigens NcSRS2, NcSAG1, NcSAG4, and Ncp40; cytoskeleton protein NCPF; dense granule proteins NcGRA2, NcGRA6, and NcGRA7; serine protease NcSUB1; and microneme (MIC) proteins NcMIC6 and NcMIC10 [25]. The indirect fluorescent antibody test (IFAT) was the first antibody-based method applied for Neospora detection [2]. In this method, intact tachyzoites are fixed onto coverslips and incubated with test serum; they are then hybridized with a fluorescein-labeled secondary antibody directed against the immunoglobulins of the hosts. IFATs have been considered the reference test for detecting neosporosis, as this test shows very little cross-reactivity with closely related apicomplexan parasites and can be quantified by titering the sera[26,27]. A direct Neospora agglutination test (NAT) has also been developed by replacing the T. gondii antigen from the modified agglutination test (MAT) with a Neosporaspecific antigen[28,29]. NAT has been used to test for the presence of IgM in a large number of sera from up to 16 different animal species and was found to be as sensitive as IFAT. However, the most extensively and commercially used serological detection method is the enzyme-linked immunosorbent assay (ELISA) [30], which can be automated for a large number of samples and scanned rapidly with high specificity. Various ELISA methods (i.e., indirect ELISAs (iELISAs) and cellular ELISAs (cELISAs)) have been established using mainly total tachyzoite lysate or purified native antigens for polystyrene plate sensitization[31,32]. One disadvantage of utilizing native or total antigens is the potential for crossreactivity with other closely related coccidian parasites [33]. Thus, a wide range of Neospora-specific antigens are currently used for coating ELISA plates in order to establish specificity[30,34,35]. ELISA-based avidity tests using IgG, IgA, and IgE antibodies have also been established to estimate the timing of infection. Other serological techniques, such as the latex agglutination test (LAT) using NcGRA6 [36] and NcSAG1 [37], and immunoblot (IB) [38], have been developed but are not widely used.

6. Seroprevalence

The presence of N. caninum antibodies in the serum of cattle, beef cattle, dogs, goats, and other domestic animals has been reported throughout the world, mostly using the abovementioned serological methods. Seroprevalence rates in cattle, dogs, goats, and sheep are depicted in Fig. 2 [3]. It is important to mention, however, that seroprevalence data from different research groups are not comparable due to the use of different serological methods, differences in cutoff values, and the lack of validation via the isolation of viable parasites from infected animals [1]. Nonetheless, viable parasites have been successfully isolated from definitive hosts in other studies particularly dogs, along with a wide range of intermediate hosts such as cattle, sheep, white-tailed deer, and water buffaloes[13]. Although it has been experimentally shown that Neospora circulate within the cattle industry exclusively between cattle and dogs, any of the abovementioned intermediate hosts may exist as additional important reservoirs for Neospora transmission. For example, white-tailed deer are one of the major reservoirs of Neospora in the United States, and have an 88% seroprevalence rate [39]. The potential for zoonotic transmission is also unknown. It has been suggested that unlike T. gondii, Neospora and Hammondia are not infectious to humans. Low titers of Neospora antibodies have been detected in humans from Brazil, Denmark, Egypt, Korea, and the United States[4042]. Although this observation can be explained by the antigenic similarity between T. gondii and Neospora, transplacental neosporosis has been described experimentally in the primate (Macaca mulatta) model[43,44] and Neospora can propagate using different human cell lines in in vitro culture [45]. Thus, these data provide clues regarding the possibility of zoonotic transmission. However, neither viable parasites nor parasitic DNA have yet been recovered from humans.
Fig. 2. Heat map of global seroprevalence of N. caninum in different hosts including cattle, dogs, goats, and sheep (-axis). The -axis represents countries/regions.

7. Molecular epidemiology

Successful molecular epidemiological and phylogenetic studies for the Neospora field require a large number of strains isolated from their extensive host and geographical range, as well as suitable genetic tools. Unlike Toxoplasma, Neospora studies lack both sufficient tools and isolates to differentiate between different Neospora strains and their mechanisms of host restriction. To date, characterization of Neospora strains has relied on a few sequenced markers that have been used to differentiate Neospora from closely related coccidia; however, these markers cannot distinguish between different Neospora strains. The most widely used molecular markers in Neospora are 18S rRNA and ITS1 regions within the small subunit ribosomal RNA (ssuRNA) and pNc5 (GenBank accession number, X84238)[43,44] due to their repetitive character, as single-copy genes are less sensitive for polymerase chain reaction (PCR) detection than multi-copy genes. Only a few singlenucleotide polymorphisms (SNPs) have been detected within the 18S rRNA gene between T. gondii, H. hammondi, and Neospora, indicating their close relationship. However, those few SNPs are adequate to differentiate Neospora from Toxoplasma and H. hammondi using universal primers, species-specific chemiluminescent DNA hybridization probes [46], a second round of nested PCR using Neospora-specific primers [47], or PCR-restricted fragment length polymorphism (PCR-RFLP) with the BsaJI enzyme [48]. Although 18S rRNA can be utilized to differentiate between closely related parasites, no sequence differences have thus far been detected between different Neospora isolates including NC1, N. caninum Liverpool (Nc-Liv), NC3, and NC-SweB1[43,44]. Another ssuRNA marker, ITS1, is also used widely for species-specific differentiation due to its high sensitivity and specificity. An ITS1-based one-tube nested PCR for Neospora was later engineered in order to increase the sensitivity to detect 1–10 fg genomic DNA of Neospora [49]. This method is also highly sensitive and specific. However, unlike the 18S rRNA locus, a difference was detected between the strain NC-Bahia (South American origin) and different canine and bovine isolates of Neospora, including NC1, Nc-Liv, BPA1, NC-SweB1, and NcNZ1, which share the identical sequence at ITS1 [15,44,50,51]. While these latter markers are extremely sensitive for detecting Neospora, they may not be suitable for characterizing intraspecific strain heterogeneity or for phylogenetic analyses due to the high degree of genetic similarity found among circulating Neospora isolates. Another multi-copy gene, pNc5, has been used extensively for the detection of Neospora infection in a wide range of intermediate and definitive hosts. However, it is not exquisitely specific, as these primers have been reported to amplify rodentspecific DNA [52]. Recently, single-gene sequenced-based markers including 14-3-3, surface antigens (SAG1, SAG4, and SRS2), secreted dense granule proteins (GRA6 and GRA7), and several housekeeping genes such as α- and β-tubulins and heat shock protein 70 (HSP-70) were developed to genotype a few bovine and canine Neospora isolates from a restricted geography [16–18,53,54]. These markers appear to be highly conserved among different Neospora isolates, which puts into question their usefulness in differentiating among Neospora isolates.
Unlike the single-copy gene sequence markers, minisatellite or microsatellite markers, which are classified as a variable number of tandem repeats (VNTR) DNA, have captured extensive genetic diversity among different isolates within the species. Thus, minisatellite and microsatellite markers have been exploited extensively for the molecular differentiation of closely related N. caninum isolates[55,56]. A genotyping study using microsatellite markers identified genetic diversity among nine isolates of N. caninum, with no association between the DNA profile of each isolate and its geographic origin [55]. In another recent study, 11 N. caninum reference isolates collected from around the world and 96 N. caninum bovine clinical isolates from Spain, Argentina, Scotland, and Germany were genotyped using nine multi-locus microsatellite markers [57]. Microsatellite characterization revealed extensive genetic diversity consisting of 96 microsatellite multi-locus genotypes. Microsatellite markers do not capture the true extent of polymorphisms throughout the genome, and may misclassify strains as variants due to homoplasy [58]. Nevertheless, clear geographic substructures were identified using these markers based on F-statistics value (FST) and eBURST analysis, which could indicate a recent introduction of N. caninum isolates with the movement of cattle industries [57]. Thus, there is a need to conduct a systematic analysis that compares the relatively non-polymorphic single-gene loci with the genetic diversity identified using microsatellite markers in order to determine the true extent of population genetic diversity. Recently, metagenomic next-generation sequencing (NGS) has evolved as a diagnostic tool to study toxoplasmic encephalitis [59]. Hence, metagenomic NGS could be developed to identify and genotype the infectious agents in a target-independent manner causally associated with neosporosis cases.

8. Genome

Although Neospora, H. hammondi, and T. gondii differ significantly in their host range and in other biological aspects such as virulence in the mouse model, their genomes are highly syntenic based on whole-genome sequencing (Table 1, Fig. 3(a))[6062]. Nc-Liv was the first Neospora genome sequenced using Sanger sequencing to eight-fold coverage; it clustered into a 61 Mb genome consisting of 585 supercontigs and 7121 genes (European Nucleotide Archive as project CADU00000000; www.toxodb.org). Subsequently, those supercontigs were reassembled using the T. gondii Me49 genome into 14 chromosomes due to their highly syntenic genomes (Fig. 3(a))[60,61]. Although Neospora and Toxoplasma diverged from their recent common ancestor approximately 28 million years ago, according to a calculation based on the mutation rate between Plasmodium falciparum and Plasmodium reichenowi [63], only a few chromosomal rearrangements and a low net gain/loss of genetic information have been observed between these two species. One exception is the significant expansion of the surface antigen families and particularly SAG1-related sequences (SRS) in Neospora (227 NcSRS genes and 52 NcSRS pseudogenes) that are tandemly arrayed in multigene clusters throughout the genome (Fig. 3(b)). Of these SRSs, Neospora only express a subset of 25 NcSRS genes during the tachyzoite stage, and only one gene is expressed per multigene cluster. Recently predicted genetic structures for over one-third of the previously annotated gene models and untranslated regions (UTRs) have been corrected based on strand-specific RNA sequencing and shotgun proteomics using tachyzoites of Nc-Liv [64]. The use of RNAseq data not only significantly improved the annotation quality of the Neospora genome, but also led to the identification of cisnatural antisense transcripts (cis-NATs) and long intergenic noncoding RNAs (lincRNAs) [64]. Interestingly, a comparative analysis of the metabolic pathways between T. gondii, H. hammondi, and N. caninum found no major changes in metabolic genes, with the exception of a few differentially expressed genes and the upregulation of nitrogen metabolism genes in N. caninum [61].
Table 1 Comparative analysis of three closely related apicomplexan parasites.
Fig. 3. Comparative analysis of closely related apicomplexan parasites N. caninum, H. hammondi, and T. gondii. (a) A Circos plot indicates highly syntenic genome among three closely related apicomplexan parasites. The outer circle represents the annotated chromosomes of each parasite. Nucleotide blast was performed among the reference sequences of these strains (www.toxodb.org) using NCBI blast V. 2.5 allowing a percent identity of 70% or more, an e-value less than 0.001, and a minimum segment size of 500 bp. Synteny among the reference sequences as found by the nucleotide blast were drawn using ribbon links in Circos V. 0.69. (b) The relative abundance of top 10 Pfam domains in T. gondii Me49 (Tg) among N. caninum (Nc) and H. hammondi (Hh) shows a significant expansion of the SAGs/SRSs domain in N. caninum.

9. Molecular genetics tools

The advent of whole-genome sequencing and transcriptional analysis has facilitated the development of molecular genetic tools to elucidate potential mechanisms of Neospora gene regulation and pathogenesis. However, it is necessary to develop genetic tools to manipulate the genome in order to elucidate functions of the genes that have been identified via genomic studies. Due to the highly syntenic[60,61] genome with T. gondii, existing heterologous expression systems available for the genetic modification of T. gondii have been initially utilized to transfect and transform Neospora successfully [65]. The Escherichia coli lacZ gene was also stably expressed in Neospora using the GRA1 promoter from T. gondii [66], and this transgenic strain became a very important tool for screening anti-parasitic molecules. Subsequently, several genes of T. gondii, including SAG1, GRA2, NTPase3, and ROP2, were also transfected into Neospora successfully, in order to gain a better understanding of the molecular mechanism of these genes. This work ultimately led to the identification of the ROP8 gene. Thus, heterologous expression of T. gondii genes into the immunologically distinct Neospora background [67] demonstrated the usefulness of studying important T. gondii genes for the development of a live vaccine candidate [68]. Following the success of a stable transfection system, mutated dihydrofolate reductasethymidylate synthase (DHFR-TS), which confers resistance to pyrimethamine [69] and the insertion of stable drug selectable markers such as chloramphenicol acetyl transferase [70] have been engineered to study genome editing in Neospora. Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)-associated gene 9 (CRISPR/Cas9) system from T. gondii has been effectively and specifically adapted for genome editing in Neospora [71]. Utilizing the CRISPR/Cas9 system, a green fluorescent protein (GFP) from an Nc-1 GFP expressing strain and the NcGRA7 gene from the Nc-Spain7 isolate have been successfully deleted and replaced with a pyrimethamine selectable marker [71]. Thus, the CRISRP/Cas9 system will provide efficient and reliable ways to make precise, targeted changes to the genome of Neospora in order to study specific gene functions [72], detect genes related to Neospora pathogenesis, or generate a live attenuated vaccine strain capable of providing immune protection against acute and chronic neosporosis.

10. Host-pathogen interaction

Over the course of evolution, hosts have developed complex immune defenses to combat pathogens, while pathogens have evolved strategies to evade host surveillance and achieve successful infection. Neospora infects a wide range of intermediate hosts. Thus, entering host cells and circumventing host immunity is paramount to its survival and persistent infection. In order to enter host cells, Neospora parasites first develop a low-affinity contact between the tachyzoite and host cell surface, followed by adhesion to the host cell. Host cell surface proteoglycans particularly chondroitin sulfate glycosaminoglycans (GAGs) for tachyzoites and terminal sialic acid residues for bradyzoites act as adhesion receptors to promote Neospora infection[73,74]. Neospora surface antigens, including NcSAG1 and NcSRS2, are the parasite factors that facilitate the initial contact between the host and parasite. Interestingly, whole-genome sequencing has identified a significant expansion of surface antigens in Neospora (223 SRS genes, Fig. 3(b)) in comparison with closely related T. gondii (135 SRS genes) [61]. This striking difference in the expansion of SRS genes and their differential impact on the modulation of initial host immunity and the regulation of parasite virulence remains unknown. After initial contact, using active gliding motility and constitutively expressed proteins present in their secretory organelles namely, MICs ROPs, and GRAs, the parasite enters the host cell through a moving junction to form PVs[7577]. Unlike the mechanism that occurs in T. gondii, an inhibitor of aspartyl protease in Neospora known as pepstatin plays an important role in assembling and trafficking the MIC and ROP proteins into host cells, and has a significant impact on parasite invasion[77,78]. Immunofluorescence studies with rabbit antiN54 identified another Neospora protease, NcSUB1 (formerly known as NC-p65), which localizes in the MIC organelles of the parasites and is involved in the invasion of host cells [79]. Formation of a moving junction leads to the injection of ROP proteins into the PV. Forward genetic-based studies, quantitative trait locus (QTL) analyses, and reverse genetic-based gene knock-out studies in T. gondii have established that ROP18/ROP5 complexes are the major virulence effectors during the infection of susceptible laboratory mice. ROP5 proteins bind to immunity-related GTPases (IRGs) to block their oligomerization and activation, following the ROP18 mediated phosphorylation of IRGs[8087]. It was recently shown that ROP18/ROP5 complexes also include another ROP kinase, ROP17, which has a high affinity toward oligomerized IRGs [88]. Interestingly, a genome-wide comparison of ROP18 sequences indicated that ROP18 is pseudogenized in Neospora and contains upstream regions (UPS) that are present in nonvirulent type III strains, but not in virulent type I and intermediately virulent type II T. gondii strains[61,89]. However, transgenic expression of ROP18 from the T. gondii type I virulent RH strain in Neospora (Nc1) makes them significantly more virulent in mice [90]. Although ROP18 is pseudogenized in Neospora, it has been well documented that interferon (IFN)- is the major cytokine mediator for resistance against Neospora [91,92]. Interestingly, IFN- activated mesenchymal stromal cells not only inhibited the growth of Neospora, but also showed the involvement of IRGs (irga6, irgb6, and irgd) and guanylate-binding proteins (GBPs; mGBP1 and mGBP2) in the anti-Neospora effect [93]. Thus, taken together, these findings suggest that pseudogenized ROP18 and the involvement of IRGs in parasite clearance are responsible for the nonvirulent phenotype of Neospora in the murine model. In addition to IFN-, Neospora is a potent activator of the toll-like receptor (TLR3) dependent type I (α/β) IFN [94]. Forward genetic studies in T. gondii also identified a nonROP2 ROP protein, ROP16, which traffics to the host cell nucleus and phosphorylates STAT3/STAT6 in a strain-specific manner, leading to significant activation of innate immune signaling, and decreasing the virulence in mice by attenuating IL-12 signals[61,95,96]. In contrast to T. gondii, Neospora ROP16 only phosphorylates STAT3 and not STAT6, resulting in the induction of host cell apoptosis [97]. ROP proteome analyses have identified other ROP components in Neospora, including NcROP1, NcROP5, and NcROP30, which have a high homology to those described in T. gondii.   
Similarly, GRAs are secreted at high levels during invasion and are expressed constitutively in the PV to modulate host signaling pathways. Although several GRAs have been identified as the critical modulators for the maturation of the PV in T. gondii [98], very few of these namely, GRA15 [99], GRA16 [100], and GRA24 [101] are associated with the host cell nucleus. GRA15 has been shown to activate the NF-κB pathway and control the induction of IL-12 secretion after T. gondii infection [99]. Conversely, GRA16 is involved in cell-cycle progression and the p53 tumor suppressor pathway [100], whereas GRA24 modulates host p38α MAP kinase [101]. In contrast to the case of T. gondii, GRAs are not well characterized in Neospora, with the exception of NcGRA6 and NcGRA7 (originally named NcDG1 [102] and NcDG2 [103]). NcGRA7 is secreted into the PV and is known to localize within the PV matrix (PVM) [76]. Other GRAs including NcGRA1, NcGRA2, NcMAG1, and NcNTPase have been characterized and are expressed within tachyzoite dense GRAs, and localize within the PV matrix [76,104]. Although GRA15 activates the NF-κB pathway in T. gondii [99], this gene is pseudogenized in Neospora.
Multiple differential and strain-specific secretory effectors have been identified that impact T. gondii host interactions and virulence in the murine model. Although strain-specific differences in Neospora have not been well studied, several instances of differential immune outcomes have been documented. For example, the reference strain Nc-Liv was shown to induce severe clinical symptoms of neosporosis in mice, including inflammatory infiltrates and highly necrotic lesions, compared with the avirulent Nc-SweB1 [105] isolate. Another nonvirulent isolate, Nc-Nowra, caused mild to moderate nonsuppurative encephalitis in laboratory mice, whereas Nc-Liv induced severe nonsuppurative encephalitis [106]. Mouse virulence analysis has also demonstrated that NC1 is more virulent than NC3 [107]. Based on these observations, it has been postulated that similar to T. gondii, differences in virulence are due to strain-specific differences in Neospora parasite factors. To support this postulation, comparative difference gel electrophoresis (DIGE) and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) techniques were conducted and showed that the proteome expression profiles differ considerably between virulent and attenuated strains; furthermore, these analyses identified unregulated expression of NTPase in virulent Neospora strains [108]. A recent Neospora immunome study revealed strain-specific differences between virulent (Nc-Liv, Nc-Spain1H) and attenuated (Nc-Spain7) strains, and showed consistently higher expression of four proteins in the virulent strains: a serine-threonine phosphatase 2C, superoxide dismutase, GAP45, and NcGRA1 [109]. As has been done for T. gondii, forward genetic analysis including the development of genetic crosses followed by QTL analysis or genome-wide association tests will potentially identify additional secretory determinants responsible for strain-specific differences in Neospora pathogenesis.

11. Vaccination

Bovine neosporosis is a huge concern worldwide due to its economic impact. According to a systematic review, economic loss by cattle neosporosis worldwide is estimated at 1.298 × 109 USD·a-1 , and ranges as high as 2.380 × 109 USD·a-1 [110]. Two-thirds of these losses were incurred by the dairy industry (8.429 × 108 USD·a-1 ), because the median-specific abortion risk due to Neospora is higher in dairy cattle (14.3%) than in beef cattle (9.1%). Moreover, two-thirds of the global losses were incurred by North America (65.7%), followed by South America (18.5%) and Australasia (10.6%), whereas losses in three European counties (the Netherlands, Spain, and the United Kingdom) were only estimated to be 5.3%. Thus, Brazil, Mexico, and the United States are the primary target markets for vaccination against neosporosis [110]. Although it has been postulated that the global market for a vaccine against cattle neosporosis is very large, there is as yet no treatment or vaccine to prevent the transmission of abortioninducing neosporosis. The only licensed N. caninum vaccine was Bovilis Neoguard (Intervet International B.V., the Netherlands), which is composed of inactivated N. caninum tachyzoites (3 × 106 mL-1 at harvest), 10% Havlogen adjuvant, 5% stabilizers, and 5% phosphate-buffered saline. Unfortunately, several follow up studies in Costa Rica and New Zealand demonstrated either low efficacy (20%) or increased transplacental transmission with increased risk of early embryonic death, ultimately leading to the withdrawal of this vaccine from the market [72,111]. Recently, a soluble fraction of tachyzoite-extract vaccine with soya lecithin/ β-glucan adjuvant (sNcAg/AVEC) showed immunogenicity and induction of high IFN- responses in pregnant cattle [112]. Nevertheless, live tachyzoite vaccines consisting of naturally attenuated or less virulent isolates such as Nc-Nowra [113], Nc-Spain1H [114], and the Argentinian isolate Nc-6 [115] provide a significant increase in N. caninum antibody responses and have led to significantly reduced abortion rates. However, there are some inherent disadvantages to using live vaccines, such as bulk preservation of live parasites and reversion risk of pathogenicity after immunization [116]; thus, inactivated or subunit vaccines are the more attractive options. Unfortunately, recombinant NcGRA7 (50– 200 μg) entrapped in oligo-mannose microsome (M3-NcGRA7) [117], as well as bacterially expressed and purified recombinant proteins including rNcSAG1, rNcHSP20, and rNcGRA7 [118], show very little promise, as they have failed to prevent infection in pregnant heifers. Therefore, the identification of a novel, more efficient vaccine approach such as live attenuated strains (including Ca2+- dependent protein kinase 2 deficient tachyzoites) of Neospora is critical to ensure long-lasting protection against neosporosis [119].

12. Conclusion

The apicomplexan parasite N. caninum is the leading cause of bovine abortion and stillbirth, or neuromuscular disorder in dogs. Bovine neosporosis has a great economic impact in both the meat and dairy industries, and no efficacious control methods exist. Thus, there is an urgent need for new drugs, vaccines, and/or tools to combat neosporosis. To identify new methods to mitigate neosporosis, it is necessary to determine its population genetic structure in order to anticipate how the pathogen is evolving; it is also necessary to better understand host-pathogen interactions. Currently available genetic markers (both RFLP and sequence based) are not adequate to distinguish among N. caninum isolates. The recent use of microsatellite markers has led to the identification of substructures within the Neospora population; however, fixation (FST) statistics and Bayesian clustering algorithms determined using microsatellite markers were confounded by a homoplasy that infers a more complex population structure than likely exists. Hence, whole-genome sequencing of multiple strains from a wide host range throughout the world should be performed. This will expand the realm of genetic markers available and generate better models to determine the extent to which transmission is occurring via asexual or sexual propagation, in order to devise better-informed strategies to reduce transmission risk and improve immune protection against acute and chronic infection of Neospora.

Acknowledgements

The authors are supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. M.E.G. is a scholar of the Canadian Institute for Advanced Research (CIFAR) Program for Integrated Microbial Biodiversity.

Compliance with ethics guidelines

Asis Khan, Jahangheer S. Shaik, Patricia Sikorski, Jitender P. Dubey, and Michael E. Grigg declare that they have no conflict of interest or financial conflicts to disclose.
[1]
Dubey JP, Schares G, Ortega-Mora LM. Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev 2007;20(2):323–67.

[2]
Dubey JP, Hattel AL, Lindsay DS, Topper MJ. Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J Am Vet Med Assoc 1988;193(10):1259–63.

[3]
Dubey JP, Hemphill A, Calero-Bernal R, Schares G. Neosporosis in animals. Boca Raton: CRC Press; 2017.

[4]
Bjerkås I, Mohn SF, Presthus J. Unidentified cyst-forming sporozoon causing encephalomyelitis and myositis in dogs. Z Parasitenkd 1984;70(2):271–4.

[5]
McAllister MM, Dubey JP, Lindsay DS, Jolley WR, Wills RA, McGuire AM. Dogs are definitive hosts of Neospora caninum. Int J Parasitol 1998;28(9):1473–9.

[6]
Gondim LF, McAllister MM, Pitt WC, Zemlicka DE. Coyotes (Canis latrans) are definitive hosts of Neospora caninum. Int J Parasitol 2004;34(2):159–61.

[7]
Dubey JP, Jenkins MC, Rajendran C, Miska K, Ferreira LR, Martins J, et al. Gray wolf (Canis lupus) is a natural definitive host for Neospora caninum. Vet Parasitol 2011;181(2–4):382–7.

[8]
King JS, Slapeta J, Jenkins DJ, Al-Qassab SE, Ellis JT, Windsor PA. Australian dingoes are definitive hosts of Neospora caninum. Int J Parasitol 2010;40 (8):945–50.

[9]
Ojo KK, Reid MC, Kallur Siddaramaiah L, Müller J, Winzer P, Zhang Z, et al. Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy. PLoS ONE 2014;9(3):e92929.

[10]
Dubey JP. Recent advances in Neospora and neosporosis. Vet Parasitol 1999;84(3–4):349–67.

[11]
Dubey JP. Neosporosis in cattle: biology and economic impact. J Am Vet Med Assoc 1999;214(8):1160–3.

[12]
Dubey JP, Ferguson DJ. Life cycle of Hammondia hammondi (Apicomplexa: Sarcocystidae) in cats. J Eukaryot Microbiol 2015;62(3):346–52.

[13]
Pare J, Thurmond MC, Hietala SK. Congenital Neospora caninum infection in dairy cattle and associated calfhood mortality. Can J Veter Res 1996;60:133–9.

[14]
Thurmond MC, Hietala SK. Effect of congenitally acquired Neospora caninum infection on risk of abortion and subsequent abortions in dairy cattle. Am J Vet Res 1997;58(12):1381–5.

[15]
Marsh AE, Barr BC, Packham AE, Conrad PA. Description of a new Neospora species (Protozoa: Apicomplexa: Sarcocystidae). J Parasitol 1998;84 (5):983–91.

[16]
Marsh AE, Howe DK, Wang G, Barr BC, Cannon N, Conrad PA. Differentiation of Neospora hughesi from Neospora caninum based on their immunodominant surface antigen, SAG1 and SRS2. Int J Parasitol 1999;29(10):1575–82.

[17]
Fernández-García A, Risco-Castillo V, Zaballos A, Alvarez-García G, OrtegaMora LM. Identification and molecular cloning of the Neospora caninum SAG4 gene specifically expressed at bradyzoite stage. Mol Biochem Parasitol 2006;146(1):89–97.

[18]
Walsh CP, Vemulapalli R, Sriranganathan N, Zajac AM, Jenkins MC, Lindsay DS. Molecular comparison of the dense granule proteins GRA6 and GRA7 of Neospora hughesi and Neospora caninum. Int J Parasitol 2001;31(3):253–8.

[19]
Dubey JP, Liddell S, Mattson D, Speer CA, Howe DK, Jenkins MC. Characterization of the Oregon isolate of Neospora hughesi from a horse. J Parasitol 2001;87(2):345–53.

[20]
Dubey JP, Lindsay DS. Gerbils (Meriones unguiculatus) are highly susceptible to oral infection with Neospora caninum oocysts. Parasitol Res 2000;86 (2):165–8.

[21]
Romano A, Inbar E, Debrabant A, Charmoy M, Lawyer P, Ribeiro-Gomes F, et al. Cross-species genetic exchange between visceral and cutaneous strains of Leishmania in the sand fly vector. Proc Natl Acad Sci USA 2014;111 (47):16808–13.

[22]
Cole RA, Lindsay DS, Dubey JP, Toivio-Kinnucan MA, Blagburn BL. Characterization of a murine monoclonal antibody generated against Neospora caninum tachyzoites by use of western blot analysis and immunoelectron microscopy. Am J Vet Res 1994;55(12):1717–22.

[23]
Lindsay DS, Dubey JP. Immunohistochemical diagnosis of Neospora caninum in tissue sections. Am J Vet Res 1989;50(11):1981–3.

[24]
Uzêda RS, Schares G, Ortega-Mora LM, Madruga CR, Aguado-Martinez A, Corbellini LG, et al. Combination of monoclonal antibodies improves immunohistochemical diagnosis of Neospora caninum. Vet Parasitol 2013;197(3–4):477–86.

[25]
McGiff JC, Laniado-Schwartzman M. Arachidonic acid metabolites and blood pressure control. Clin Physiol Biochem 1988;6(3–4):179–87.

[26]
Trees AJ, Guy F, Tennant BJ, Balfour AH, Dubey JP. Prevalence of antibodies to Neospora caninum in a population of urban dogs in England. Vet Rec 1993;132 (6):125–6.

[27]
Dubey JP, Lindsay DS, Adams DS, Gay JM, Baszler TV, Blagburn BL, et al. Serologic responses of cattle and other animals infected with Neospora caninum. Am J Vet Res 1996;57(3):329–36.

[28]
Packham AE, Sverlow KW, Conrad PA, Loomis EF, Rowe JD, Anderson ML, et al. A modified agglutination test for Neospora caninum: development, optimization, and comparison to the indirect fluorescent-antibody test and enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 1998;5 (4):467–73.

[29]
Romand S, Thulliez P, Dubey JP. Direct agglutination test for serologic diagnosis of Neospora caninum infection. Parasitol Res 1997;84(1):50–3.

[30]
Sinnott FA, Monte LG, Collares TF, Silveira RM, Borsuk S. Review on the immunological and molecular diagnosis of neosporosis (years 2011–2016). Vet Parasitol 2017;239:19–25.

[31]
Von Blumröder D, Schares G, Norton R, Williams DJ, Esteban-Redondo I, Wright S, et al. Comparison and standardisation of serological methods for the diagnosis of Neospora caninum infection in bovines. Vet Parasitol 2004;120(1–2):11–22.

[32]
Williams DJ, Davison HC, Helmick B, McGarry J, Guy F, Otter A, et al. Evaluation of a commercial ELISA for detecting serum antibody to Neospora caninum in cattle. Vet Rec 1999;145(20):571–5.

[33]
Ybañez RH, Terkawi MA, Kameyama K, Xuan X, Nishikawa Y. Identification of a highly antigenic region of subtilisin-like serine protease 1 for serodiagnosis of Neospora caninum infection. Clin Vaccine Immunol 2013;20(10):1617–22.

[34]
Ghalmi F, China B, Kaidi R, Losson B. Evaluation of a SRS2 sandwich commercial enzyme-linked immunosorbent assay for the detection of antiNeospora caninum antibodies in bovine and canine sera. J Vet Diagn Invest 2009;21(1):108–11.

[35]
Baszler TV, Adams S, Vander-Schalie J, Mathison BA, Kostovic M. Validation of a commercially available monoclonal antibody-based competitive-inhibition enzyme-linked immunosorbent assay for detection of serum antibodies to Neospora caninum in cattle. J Clin Microbiol 2001;39(11):3851–7.

[36]
Ghalmi F, China B, Jenkins M, Azzag N, Losson B. Comparison of different serological methods to detect antibodies specific to Neospora caninum in bovine and canine sera. J Vet Diagn Invest 2014;26(1):136–40.

[37]
Moraveji M, Hosseini A, Moghaddar N, Namavari MM, Eskandari MH. Development of latex agglutination test with recombinant NcSAG1 for the rapid detection of antibodies to Neospora caninum in cattle. Vet Parasitol 2012;189(2–4):211–7.

[38]
Hu J, Ferroglio E, Trisciuoglio A. Immunoblot diagnosis of infection with Neospora caninum in cattle based on recombinant NcSAG4 antigen. Parasitol Res 2011;108(4):1055–8.

[39]
Rosypal AC, Lindsay DS. The sylvatic cycle of Neospora caninum: where do we go from here? Trends Parasitol 2005;21(10):439–40.

[40]
Nam HW, Kang SW, Choi WY. Antibody reaction of human anti-Toxoplasma gondii positive and negative sera with Neospora caninum antigens. Korean J Parasitol 1998;36(4):269–75.

[41]
Petersen E, Lebech M, Jensen L, Lind P, Rask M, Bagger P, et al. Neospora caninum infection and repeated abortions in humans. Emerg Infect Dis 1999;5(2):278–80.

[42]
Lobato J, Silva DA, Mineo TW, Amaral JD, Segundo GR, Costa-Cruz JM, et al. Detection of immunoglobulin G antibodies to Neospora caninum in humans: high seropositivity rates in patients who are infected by human immunodeficiency virus or have neurological disorders. Clin Vaccine Immunol 2006;13(1):84–9.

[43]
Marsh AE, Barr BC, Sverlow K, Ho M, Dubey JP, Conrad PA. Sequence analysis and comparison of ribosomal DNA from bovine Neospora to similar coccidial parasites. J Parasitol 1995;81(4):530–5.

[44]
Stenlund S, Björkman C, Holmdahl OJ, Kindahl H, Uggla A. Characterization of a Swedish bovine isolate of Neospora caninum. Parasitol Res 1997;83 (3):214–9.

[45]
Lindsay DS, Dubey JP. Evaluation of anti-coccidial drugs’ inhibition of Neospora caninum development in cell cultures. J Parasitol 1989;75(6):990–2.

[46]
Ho MS, Barr BC, Marsh AE, Anderson ML, Rowe JD, Tarantal AF, et al. Identification of bovine Neospora parasites by PCR amplification and specific small-subunit rRNA sequence probe hybridization. J Clin Microbiol 1996;34 (5):1203–8.

[47]
Ellis JT. Polymerase chain reaction approaches for the detection of Neospora caninum and Toxoplasma gondii. Int J Parasitol 1998;28(7):1053–60.

[48]
Magnino S, Vigo PG, Fabbi M, Colombo M, Bandi C, Genchi C. Isolation of a bovine Neospora from a newborn calf in Italy. Vet Rec 1999;144(16):456.

[49]
Ellis JT, McMillan D, Ryce C, Payne S, Atkinson R, Harper PA. Development of a single tube nested polymerase chain reaction assay for the detection of Neospora caninum DNA. Int J Parasitol 1999;29(10):1589–96.

[50]
Gondim LF, Laski P, Gao L, McAllister MM. Variation of the internal transcribed spacer 1 sequence within individual strains and among different strains of Neospora caninum. J Parasitol 2004;90(1):119–22.

[51]
Dubey JP, Vianna MC, Kwok OC, Hill DE, Miska KB, Tuo W, et al. Neosporosis in Beagle dogs: clinical signs, diagnosis, treatment, isolation and genetic characterization of Neospora caninum. Vet Parasitol 2007;149(3–4):158–66.

[52]
Muradian V, Ferreira LR, Lopes EG, De Oliveira Esmerini P, De Jesus Pena HF, Soares RM, et al. A survey of Neospora caninum and Toxoplasma gondii infection in urban rodents from Brazil. J Parasitol 2012;98(1):128–34.

[53]
McInnes LM, Irwin P, Palmer DG, Ryan UM. In vitro isolation and characterisation of the first canine Neospora caninum isolate in Australia. Vet Parasitol 2006;137(3–4):355–63.

[54]
Siverajah S, Ryce C, Morrison DA, Ellis JT. Characterization of an alpha tubulin gene sequence from Neospora caninum and Hammondia heydorni, and their comparison to homologous genes from Apicomplexa. Parasitology 2003;126 (Pt 6):561–9.

[55]
Regidor-Cerrillo J, Pedraza-Díaz S, Gómez-Bautista M, Ortega-Mora LM. Multilocus microsatellite analysis reveals extensive genetic diversity in Neospora caninum. J Parasitol 2006;92(3):517–24.

[56]
Basso W, Schares S, Bärwald A, Herrmann DC, Conraths FJ, Pantchev N, et al. Molecular comparison of Neospora caninum oocyst isolates from naturally infected dogs with cell culture-derived tachyzoites of the same isolates using nested polymerase chain reaction to amplify microsatellite markers. Vet Parasitol 2009;160(1–2):43–50.

[57]
Regidor-Cerrillo J, Díez-Fuertes F, García-Culebras A, Moore DP, GonzálezWarleta M, Cuevas C, et al. Genetic diversity and geographic population structure of bovine Neospora caninum determined by microsatellite genotyping analysis. PLoS One 2013;8(8):e72678.

[58]
Adams RI, Brown KM, Hamilton MB. The impact of microsatellite electromorph size homoplasy on multilocus population structure estimates in a tropical tree (Corythophora alta) and an anadromous fish (Morone saxatilis). Mol Ecol 2004;13(9):2579–88

[59]
Hu Z, Weng X, Xu C, Lin Y, Cheng C, Wei H, et al. Metagenomic nextgeneration sequencing as a diagnostic tool for toxoplasmic encephalitis. Ann Clin Microbiol Antimicrob 2018;17(1):45.

[60]
DeBarry JD, Kissinger JC. Jumbled genomes: missing Apicomplexan synteny. Mol Biol Evol 2011;28(10):2855–71.

[61]
Reid AJ, Vermont SJ, Cotton JA, Harris D, Hill-Cawthorne GA, Könen-Waisman S, et al. Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum: Coccidia differing in host range and transmission strategy. PLoS Pathog 2012;8(3):e1002567.

[62]
Lorenzi H, Khan A, Behnke MS, Namasivayam S, Swapna LS, Hadjithomas M, et al. Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes. Nat Commun 2016;7(1):10147.

[63]
Ricklefs RE, Outlaw DC. A molecular clock for malaria parasites. Science 2010;329(5988):226–9.

[64]
Ramaprasad A, Mourier T, Naeem R, Malas TB, Moussa E, Panigrahi A, et al. Comprehensive evaluation of Toxoplasma gondii VEG and Neospora caninum LIV genomes with tachyzoite stage transcriptome and proteome defines novel transcript features. PLoS One 2015;10(4):e0124473.

[65]
Howe DK, Sibley LD. Development of molecular genetics for Neospora caninum: a complementary system to Toxoplasma gondii. Methods 1997;13 (2):123–33.

[66]
Howe DK, Mercier C, Messina M, Sibley LD. Expression of Toxoplasma gondii genes in the closely-related apicomplexan parasite Neospora caninum. Mol Biochem Parasitol 1997;86(1):29–36.

[67]
Beckers CJ, Wakefield T, Joiner KA. The expression of Toxoplasma proteins in Neospora caninum and the identification of a gene encoding a novel rhoptry protein. Mol Biochem Parasitol 1997;89(2):209–23.

[68]
Zhang G, Huang X, Boldbaatar D, Battur B, Battsetseg B, Zhang H, et al. Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice. Vaccine 2010;28(45):7243–7.

[69]
Pereira LM, Baroni L, Yatsuda AP. A transgenic Neospora caninum strain based on mutations of the dihydrofolate reductase-thymidylate synthase gene. Exp Parasitol 2014;138:40–7.

[70]
Pereira LM, Yatsuda AP. The chloramphenicol acetyltransferase vector as a tool for stable tagging of Neospora caninum. Mol Biochem Parasitol 2014;196 (2):75–81.

[71]
Arranz-Solís D, Regidor-Cerrillo J, Lourido S, Ortega-Mora LM, Saeij JPJ. Toxoplasma CRISPR/Cas9 constructs are functional for gene disruption in Neospora caninum. Int J Parasitol 2018;48(8):597–600.

[72]
Romero JJ, Pérez E, Frankena K. Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions. Vet Parasitol 2004;123(3–4):149–59.

[73]
Naguleswaran A, Cannas A, Keller N, Vonlaufen N, Björkman C, Hemphill A. Vero cell surface proteoglycan interaction with the microneme protein NcMIC(3) mediates adhesion of Neospora caninum tachyzoites to host cells unlike that in Toxoplasma gondii. Int J Parasitol 2002;32(6):695–704.

[74]
Vonlaufen N, Guetg N, Naguleswaran A, Müller N, Björkman C, Schares G, et al. In vitro induction of Neospora caninum bradyzoites in Vero cells reveals differential antigen expression, localization, and host-cell recognition of tachyzoites and bradyzoites. Infect Immun 2004;72(1):576–83.

[75]
English ED, Adomako-Ankomah Y, Boyle JP. Secreted effectors in Toxoplasma gondii and related species: determinants of host range and pathogenesis? Parasite Immunol 2015;37(3):127–40.

[76]
Hemphill A, Gajendran N, Sonda S, Fuchs N, Gottstein B, Hentrich B, et al. Identification and characterisation of a dense granule-associated protein in Neospora caninum tachyzoites. Int J Parasitol 1998;28(3):429–38.

[77]
Hemphill A, Vonlaufen N, Naguleswaran A. Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum. Parasitology 2006;133(Pt 03):261–78.

[78]
Naguleswaran A, Müller N, Hemphill A. Neospora caninum and Toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions. Exp Parasitol 2003;104(3–4):149–58.

[79]
Louie K, Nordhausen R, Robinson TW, Barr BC, Conrad PA. Characterization of Neospora caninum protease, NcSUB1 (NC-P65), with rabbit anti-N54. J Parasitol 2002;88(6):1113–9.

[80]
Taylor S, Barragan A, Su C, Fux B, Fentress SJ, Tang K, et al. A secreted serinethreonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 2006;314(5806):1776–80.

[81]
Saeij JPJ, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 2006;314(5806):1780–3.

[82]
Fentress SJ, Behnke MS, Dunay IR, Mashayekhi M, Rommereim LM, Fox BA, et al. Phosphorylation of immunity-related GTPases by a parasite secretory kinase promotes macrophage survival and virulence. Cell Host Microbe 2010;8(6):484–95.

[83]
Fentress SJ, Sibley LD. The secreted kinase ROP18 defends Toxoplasma’s border. BioEssays 2011;33(9):693–700.

[84]
Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, Sibley LD. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci USA 2011;108(23):9631–6.

[85]
Behnke MS, Khan A, Lauron EJ, Jimah JR, Wang Q, Tolia NH, et al. Rhoptry proteins ROP5 and ROP18 are major murine virulence factors in genetically divergent South American strains of Toxoplasma gondii. PLoS Genet 2015;11 (8):e1005434.

[86]
Reese ML, Boothroyd JC. A conserved non-canonical motif in the pseudoactive site of the ROP5 pseudokinase domain mediates its effect on Toxoplasma virulence. J Biol Chem 2011;286(33):29366–75.

[87]
Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci USA 2011;108(23):9625–30.

[88]
Etheridge RD, Alaganan A, Tang K, Lou HJ, Turk BE, Sibley LD. The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. Cell Host Microbe 2014;15 (5):537–50.

[89]
Khan A, Taylor S, Ajioka JW, Rosenthal BM, Sibley LD. Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice. PLoS Genet 2009;5(3):e1000404.

[90]
Lei T, Wang H, Liu J, Nan H, Liu Q. ROP18 is a key factor responsible for virulence difference between Toxoplasma gondii and Neospora caninum. PLoS One 2014;9(6):e99744.

[91]
Baszler TV, Long MT, McElwain TF, Mathison BA. Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice. Int J Parasitol 1999;29(10):1635–46.

[92]
Nishikawa Y, Tragoolpua K, Inoue N, Makala L, Nagasawa H, Otsuka H, et al. In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages. Clin Diagn Lab Immunol 2001;8 (4):811–6.

[93]
Spekker K, Leineweber M, Degrandi D, Ince V, Brunder S, Schmidt SK, et al. Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs). Med Microbiol Immunol 2013;202(3):197–206.

[94]
Beiting DP, Peixoto L, Akopyants NS, Beverley SM, Wherry EJ, Christian DA, et al. Differential induction of TLR3-dependent innate immune signaling by closely related parasite species. PLoS One 2014;9(2):e88398.

[95]
Saeij JPJ, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 2007;445(7125):324–7.

[96]
Hunter CA, Sibley LD. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol 2012;10(11):766–78.

[97]
Ma L, Liu G, Liu J, Li M, Zhang H, Tang D, et al. Neospora caninum ROP16 play an important role in the pathogenicity by phosphorylating host cell STAT3. Vet Parasitol 2017;243:135–47.

[98]
Mercier C, Cesbron-Delauw MF. Toxoplasma secretory granules: one population or more? Trends Parasitol 2015;31(2):60–71.

[99]
Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, Jensen KD, et al. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med 2011;208(1):195–212.

[100]
Bougdour A, Durandau E, Brenier-Pinchart MP, Ortet P, Barakat M, Kieffer S, et al. Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression. Cell Host Microbe 2013;13(4):489–500.

[101]
Braun L, Brenier-Pinchart MP, Yogavel M, Curt-Varesano A, Curt-Bertini RL, Hussain T, et al. A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation. J Exp Med 2013;210(10):2071–86.

[102]
Lally N, Jenkins M, Liddell S, Dubey JP. A dense granule protein (NCDG1) gene from Neospora caninum. Mol Biochem Parasitol 1997;87(2):239–43.

[103]
Liddell S, Lally NC, Jenkins MC, Dubey JP. Isolation of the cDNA encoding a dense granule associated antigen (NCDG2) of Neospora caninum. Mol Biochem Parasitol 1998;93(1):153–8.

[104]
Pastor-Fernández I, Regidor-Cerrillo J, Álvarez-García G, Marugán-Hernández V, García-Lunar P, Hemphill A, et al. The tandemly repeated NTPase (NTPDase) from Neospora caninum is a canonical dense granule protein whose RNA expression, protein secretion and phosphorylation coincides with the tachyzoite egress. Parasit Vectors 2016;9(1):352.

[105]
Atkinson R, Harper PA, Ryce C, Morrison DA, Ellis JT. Comparison of the biological characteristics of two isolates of Neospora caninum. Parasitology 1999;118(Pt 4):363–70.

[106]
Miller CM, Quinn HE, Windsor PA, Ellis JT. Characterisation of the first Australian isolate of Neospora caninum from cattle. Aust Vet J 2002;80 (10):620–5.

[107]
Lindsay DS, Lenz SD, Cole RA, Dubey JP, Blagburn BL. Mouse model for central nervous system Neospora caninum infections. J Parasitol 1995;81 (2):313–5.

[108]
Regidor-Cerrillo J, Álvarez-García G, Pastor-Fernández I, Marugán-Hernández V, Gómez-Bautista M, Ortega-Mora LM. Proteome expression changes among virulent and attenuated Neospora caninum isolates. J Proteomics 2012;75 (8):2306–18.

[109]
Regidor-Cerrillo J, García-Lunar P, Pastor-Fernández I, Álvarez-García G, Collantes-Fernández E, Gómez-Bautista M, et al. Neospora caninum tachyzoite immunome study reveals differences among three biologically different isolates. Vet Parasitol 2015;212(3–4):92–9.

[110]
Reichel MP, Alejandra Ayanegui-Alcérreca M, Gondim LF, Ellis JT. What is the global economic impact of Neospora caninum in cattle the billion dollar question. Int J Parasitol 2013;43(2):133–42.

[111]
Weston JF, Heuer C, Williamson NB. Efficacy of a Neospora caninum killed tachyzoite vaccine in preventing abortion and vertical transmission in dairy cattle. Prev Vet Med 2012;103(2–3):136–44.

[112]
Mansilla FC, Moore DP, Quintana ME, Cardoso N, Hecker YP, Gual I, et al. Safety and immunogenicity of a soluble native Neospora caninum tachyzoite-extract vaccine formulated with a soy lecithin/b-glucan adjuvant in pregnant cattle. Vet Immunol Immunopathol 2015;165(1–2): 75–80.

[113]
Weber FH, Jackson JA, Sobecki B, Choromanski L, Olsen M, Meinert T, et al. On the efficacy and safety of vaccination with live tachyzoites of Neospora caninum for prevention of neospora-associated fetal loss in cattle. Clin Vaccine Immunol 2013;20(1):99–105.

[114]
Rojo-Montejo S, Collantes-Fernández E, Pérez-Zaballos F, Rodríguez-Marcos S, Blanco-Murcia J, Rodríguez-Bertos A, et al. Effect of vaccination of cattle with the low virulence Nc-Spain 1H isolate of Neospora caninum against a heterologous challenge in early and mid-gestation. Vet Res 2013;44 (1):106.

[115]
Hecker YP, Moore DP, Quattrocchi V, Regidor-Cerrillo J, Verna A, Leunda MR, et al. Immune response and protection provided by live tachyzoites and native antigens from the NC-6 Argentina strain of Neospora caninum in pregnant heifers. Vet Parasitol 2013;197(3–4):436–46.

[116]
Reichel MP, Moore DP, Hemphill A, Ortega-Mora LM, Dubey JP, Ellis JT. A live vaccine against Neospora caninum abortions in cattle. Vaccine 2015;33 (11):1299–301.

[117]
Nishimura M, Kohara J, Kuroda Y, Hiasa J, Tanaka S, Muroi Y, et al. Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to Neospora caninum in cattle. Vaccine 2013;31 (35):3528–35.

[118]
Hecker YP, Cóceres V, Wilkowsky SE, Jaramillo Ortiz JM, Morrell EL, Verna AE, et al. A Neospora caninum vaccine using recombinant proteins fails to prevent foetal infection in pregnant cattle after experimental intravenous challenge. Vet Immunol Immunopathol 2014;162(3–4):142–53.

[119]
Wang JL, Li TT, Elsheikha HM, Chen K, Cong W, Yang WB, et al. Live attenuated Pru: Dcdpk2 strain of Toxoplasma gondii protects against acute, chronic, and congenital toxoplasmosis. J Infect Dis 2018;218(5):768–77.

Outlines

/